271 related articles for article (PubMed ID: 37090044)
1. Detection of paraneoplastic antibodies and their significance in paraneoplastic neurologic syndromes: a narrative review.
Li L; Guo Y; Wang J
Ann Transl Med; 2023 Apr; 11(7):283. PubMed ID: 37090044
[TBL] [Abstract][Full Text] [Related]
2. Clinical approach to diagnosis of paraneoplastic neurologic syndromes.
Graus F
Handb Clin Neurol; 2024; 200():79-96. PubMed ID: 38494298
[TBL] [Abstract][Full Text] [Related]
3. Pathogenesis, diagnosis and treatment of paraneoplastic neurologic syndromes.
Blaes F
Expert Rev Neurother; 2021 Jun; 21(6):675-686. PubMed ID: 33960258
[No Abstract] [Full Text] [Related]
4. A large screen for paraneoplastic neurological autoantibodies; diagnosis and predictive values.
Seluk L; Taliansky A; Yonath H; Gilburd B; Amital H; Shoenfeld Y; Kivity S
Clin Immunol; 2019 Feb; 199():29-36. PubMed ID: 30543927
[TBL] [Abstract][Full Text] [Related]
5. Updates in the Management of Paraneoplastic Syndrome.
Verma N; Jaffer MH; Kolli AS; Mokhtari S
Semin Neurol; 2024 Feb; 44(1):36-46. PubMed ID: 38183975
[TBL] [Abstract][Full Text] [Related]
6. "Non-classical" paraneoplastic neurological syndromes associated with well-characterized antineuronal antibodies as compared to "classical" syndromes - More frequent than expected.
Berger B; Bischler P; Dersch R; Hottenrott T; Rauer S; Stich O
J Neurol Sci; 2015 May; 352(1-2):58-61. PubMed ID: 25824848
[TBL] [Abstract][Full Text] [Related]
7. Onconeuronal and antineuronal antibodies in patients with neoplastic and non-neoplastic pulmonary pathologies and suspected for paraneoplastic neurological syndrome.
Michalak S; Cofta S; Piatek A; Rybacka J; Wysocka E; Kozubski W
Eur J Med Res; 2009 Dec; 14 Suppl 4(Suppl 4):156-61. PubMed ID: 20156748
[TBL] [Abstract][Full Text] [Related]
8. Paraneoplastic neurological syndrome: growing spectrum and relevance.
Ganaraja VH; Rezk M; Dubey D
Neurol Sci; 2022 Jun; 43(6):3583-3594. PubMed ID: 35460452
[TBL] [Abstract][Full Text] [Related]
9. [Paraneoplastic neurological syndrome and autoantibodies].
Hayashi Y; Inuzuka T
Brain Nerve; 2013 Apr; 65(4):385-93. PubMed ID: 23568986
[TBL] [Abstract][Full Text] [Related]
10. Paraneoplastic antigens as biomarkers for early diagnosis of ovarian cancer.
Chatterjee M; Hurley LC; Tainsky MA
Gynecol Oncol Rep; 2017 Aug; 21():37-44. PubMed ID: 28653032
[TBL] [Abstract][Full Text] [Related]
11. Clinical neuropathology practice guide 5-2012: updated guideline for the diagnosis of antineuronal antibodies.
Höftberger R; Dalmau J; Graus F
Clin Neuropathol; 2012; 31(5):337-41. PubMed ID: 22939174
[TBL] [Abstract][Full Text] [Related]
12. Paraneoplastic Neurological Syndromes: Transitioning Between the Old and the New.
Gastaldi M; Scaranzin S; Pietro B; Lechiara A; Pesce G; Franciotta D; Lorusso L
Curr Oncol Rep; 2022 Oct; 24(10):1237-1249. PubMed ID: 35476177
[TBL] [Abstract][Full Text] [Related]
13. Antibodies to neural cell surface and synaptic proteins in paraneoplastic neurologic syndromes.
Budhram A; Sechi E
Handb Clin Neurol; 2024; 200():347-364. PubMed ID: 38494289
[TBL] [Abstract][Full Text] [Related]
14. [Neurological syndromes, encephalitis].
Yamamoto T; Tsuji S
Gan To Kagaku Ryoho; 2010 Jun; 37(6):995-1005. PubMed ID: 20567100
[TBL] [Abstract][Full Text] [Related]
15. Paraneoplastic Neurological Syndromes and Glutamic Acid Decarboxylase Antibodies.
Ariño H; Höftberger R; Gresa-Arribas N; Martínez-Hernández E; Armangue T; Kruer MC; Arpa J; Domingo J; Rojc B; Bataller L; Saiz A; Dalmau J; Graus F
JAMA Neurol; 2015 Aug; 72(8):874-81. PubMed ID: 26099072
[TBL] [Abstract][Full Text] [Related]
16. Caveats and Pitfalls of SOX1 Autoantibody Testing With a Commercial Line Blot Assay in Paraneoplastic Neurological Investigations.
Ruiz-García R; Martínez-Hernández E; García-Ormaechea M; Español-Rego M; Sabater L; Querol L; Illa I; Dalmau J; Graus F
Front Immunol; 2019; 10():769. PubMed ID: 31031763
[TBL] [Abstract][Full Text] [Related]
17. Paraneoplastic neurological syndromes with onconeural antibodies: A single center retrospective study.
Oliveira V; Videira G; Samões R; Carneiro P; Neves E; Santos E
J Neurol Sci; 2020 Nov; 418():117103. PubMed ID: 32877801
[TBL] [Abstract][Full Text] [Related]
18. Paraneoplastic autoantibody panels: sensitivity and specificity, a retrospective cohort.
Albadareen R; Gronseth G; Goeden M; Sharrock M; Lechtenberg C; Wang Y
Int J Neurosci; 2017 Jun; 127(6):531-538. PubMed ID: 27356679
[TBL] [Abstract][Full Text] [Related]
19. Serum and Cerebrospinal Fluid Testing in Optic Neuropathy Patients with Malignant Tumors.
Sun CB; Liu GH; Xiao Q; Zhao YN; Ren Q
Dis Markers; 2022; 2022():7076385. PubMed ID: 35222744
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
